Skip to main content

Table 3 Comparison of CRS and HIPEC in the experimental and control groups

From: Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study

  Experimental group (N = 8) Control group (N = 88)
Median duration of hospital stay 15 days (range 2–38) 15 days (range 4–63)
Median length of surgery (min) 485 (339–617) 502.50 (122–992)
Median blood loss (mL) 750 (100–2500) 700 (100–7000)
Resected organs
Hemicolectomy 2/8 43/110
(Sub)total colectomy 0/8 10/110
Pelvic peritoneum 6/8 81/110
Splenectomy 3/8 31/110
Small bowel resection 4/8 26/110
Cholecystectomy 2/8 23/110
  1. CRS cytoreductive surgery, HIPEC hyperthermic intraperitoneal chemotherapy